The global organoids market was capitalized for USD 730.2 Million in 2019 and is estimated to reach USD 3,595.5 Million by the end of 2025, developing at a compound annual growth rate (CAGR) of over 22.8% during the forecast period 2019–2025. Organoids usually grow from the stem cells which can divide indefinitely and also produce various types of cells as a part of their progeny. The application of organoids in drug discovery helps in reducing the extremely time-consuming process and also saves expenditure, adding to the need of organoids in the market.
Major key players in the market are PeproTech, Inc., Thermo Fisher Scientific, Corning Incorporated (Life Sciences, STEMCELL Technologies, Inc., Cellesce Ltd., Hubrecht Organoid Technology, Definigen, 3Dnamics, Inc., Organoid Therapeutics, Merck KGgA, others
Rising adoption of personalized drugs to boost the global organoids market
The application of organoids for creating the personalized drug therapies is offering some exciting opportunities to improve the patient care. A recent research has emphasised that more than 50 percent of the consumers are expressing an interest in purchasing the customized products and services. Increasing demand for personalized tumor simulation studies in preclinical settings to validate the practical dimensions of genomic drug response prediction. Thus, higher adoption of the personalized drugs help in boosting the global organoids market growth.
The global organoids market is bifurcated on the basis of the source, product type, application, end-user, and regional analysis. Based on the source, the market is divided into pluripotent stem cells and organ-specific adult stem cells. Based on the product type, the market is divided into intestinal organoids, neural organoids, pancreatic organoids, hepatic organoids, colorectal organoids and others. Based on application, the market is divided into biomedical research and drug discovery, bio-banking, regenerative medicine, therapeutic tools, cancer research and others. Based on the end-user, the market is divided into biopharmaceutical companies, academics and research institutes and contract research organizations.
Access Sample Report - Clcik Here
The Asia Pacific Region Expected to Witness fastest Growth in the Global Organoids Market
On the basis of geographical analysis, the global organoids market is divided into North America, Europe, Latin America, Asia Pacific, and Middle East & Africa. The growth of the organoids market across Asia Pacific is due to the surge in healthcare expenditure and new technological advancements. Moreover, increasing collaboration between medical experts and researchers are expected to accelerate the growth of complex organoids. For example, two recent discoveries are estimated to fuel the overall prospects of next generation organoid development. In August 2020, a new research collaboration was announced between Japan and scientists from the Cincinnati Children’s.
“Organoids Market - By Application (Biomedical Research and Drug Discovery, Bio-banking, Regenerative Medicine, Therapeutic Tools, Cancer Research, Others), By Product Type (Hepatic Organoids, Colorectal Organoids, Intestinal Organoids, Neural Organoids, Pancreatic Organoids ,Others), By End-User (Biopharmaceutical Companies, Academics and Research Institutes, Contract Research Organizations), By Source (Pluripotent Stem Cells, Organ-Specific Adult Stem Cells), and By Region (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) - Global Comprehensive Analysis, Forecast (2019-2025), Industry Perspective.”
The global organoids market is segmented as follows:
• Pluripotent Stem Cells
• Organ-Specific Adult Stem Cells
By Product Type:
• Intestinal Organoids
• Neural Organoids
• Pancreatic Organoids
• Hepatic Organoids
• Colorectal Organoids
• Biomedical Research and Drug Discovery
• Regenerative Medicine
• Therapeutic Tools
• Cancer Research
• Biopharmaceutical Companies
• Academics and Research Institutes
• Contract Research Organizations
• North America
o The U.S.
o The UK
o Rest of Europe
• Asia Pacific
o South Korea
o Southeast Asia
o Rest of Asia Pacific
• Latin America
o Rest of Latin America
• Middle East & Africa
o South Africa
o Rest of Middle East & Africa
FAST.MR is a global market research and business-consulting organization that aims to provide a deep market insight to our clients, which helps them in better decision making in the dynamic environment. We have a team of highly qualified personnel that studies the market in-depth to provide our clients with better strategies to stand out in the market.
Our report covers the current market status, opportunities available in the market, growth plans, and emerging trends in order to cater to the evolving needs of the customers. We help businesses around the globe with operational improvements, technologies, emerging market trends that in-depth boost the company’s growth in the future. The reports prepared by us are customized according to the client’s needs. We inculcate high morale and ethics while preparing our report which helps in building long-term relationships with our clients.